Skip to content
Imago BioSciences, Inc. logo — Pioneering innovative therapies to conquer challenging disea...

Imago BioSciences, Inc.

Pioneering innovative therapies to conquer challenging diseases, enabling patients to lead longer, healthier lives.

Founded 2012 United States San Carlos, United States 5 employees Series C Total: $146.50M Biotechnology, Health and Wellness +1

General Information

Company Name Imago BioSciences, Inc.
Founded Year 2012
Location United States San Carlos, United States
Employees 5
Industries Biotechnology, Health and Wellness, Life Sciences
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Imago BioSciences, Inc.. To contact Imago BioSciences, Inc., visit imagobio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Imago BioSciences, Inc. compare?

A PDF of Imago BioSciences, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Imago BioSciences, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Imago BioSciences, Inc.

Imago BioSciences, established in 2012 and headquartered in Redwood City, California, is committed to advancing state-of-the-art science into innovative treatments for challenging diseases. The company's last investment of $80.00M in Series C took place on 19 November 2020. Imago BioSciences focuses on a select group of orphan diseases, translating its unique scientific insights into impactful therapies. With the support of notable investors such as Amgen Ventures, Greenspring Associates, BlackRock, Frazier Healthcare Partners, Xeraya Capital, MRL Ventures Fund, Kingdon Capital Management, Farallon Capital Management, Pharmaron, and Surveyor Capital, the company aims to pioneer innovative therapies that significantly alter the progression of diseases. Imago BioSciences' mission is to enable patients to lead longer, healthier lives.

Business keywords: clinical development, therapeutics, innovative treatments, orphan diseases, state-of-the-art science, disease progression, transformative therapies, medical research, financial support, investors, therapeutic innovation, Redwood City, California

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $80.00M 10
Amgen Ventures, Greenspring Associates +8
19 Nov 2020
Series B $40.00M -
21 Mar 2019
Series A $26.50M -
31 Oct 2014

Imago BioSciences, Inc. Alternatives & Competitors

View All Alternatives
Imago BioSciences, Inc. vs
Evommune
Evommune United States

Developing innovative therapies that target key drivers of chronic inflammatory diseases.

69 employees
Biotechnology, Health Care
Imago BioSciences, Inc. vs

Pioneering breakthrough treatments for central nervous system diseases through innovative gene disco...

Series C
Biopharma, Biotechnology
Imago BioSciences, Inc. vs

Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the disease

Series A
70 employees
Biotechnology, Health Care

FAQ About Imago BioSciences, Inc.

Pioneering innovative therapies to conquer challenging diseases, enabling patients to lead longer, healthier lives.
Imago BioSciences, Inc. was founded in 2012.
Imago BioSciences, Inc. is headquartered in San Carlos, United States.
Imago BioSciences, Inc. operates in Biotechnology, Health and Wellness and Life Sciences. Its work centres on clinical development, therapeutics, innovative treatments and orphan diseases.
Imago BioSciences, Inc. has approximately 5 employees.
Imago BioSciences, Inc. has completed 3 funding rounds, raising a total of $146.50M. The latest funding stage is Series C.
Top alternatives and competitors to Imago BioSciences, Inc. include Evommune, AGY Therapeutics, AAVantgarde, Rezolute, Inc., Solu Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Imago BioSciences, Inc. and Evommune are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Imago BioSciences, Inc., https://bouncewatch.com/company/imago-biosciences, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout